Skip to content

Effect of Head-neck Rotation on I-gel™ Insertion

Effect of Head-neck Rotation on the Success Rate At First Attempt of I-gel™ Insertion

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05201339
Enrollment
172
Registered
2022-01-21
Start date
2022-02-25
Completion date
2023-06-02
Last updated
2024-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Supraglottic Airway Device, Intubation; Difficult or Failed, Airway Complication of Anesthesia

Keywords

Supraglottic airway device, Intubation, Airway

Brief summary

According to previous studies, head and neck rotation reduces the tongue from being rolled back by gravity, which resulted in increasing patency of the upper airway. Therefore, the purpose of this study is to verify whether head and neck rotation increases the first attempt success rate of i-gel™.

Detailed description

I-gel™ insertion has been reported that the success rate of insertion on the first attempt is 78.5%. There may be several causes of insertion failure. Tongue folding is a major obstacle preventing appropriate i-gel™ placement. To solve this problem, the previous study has proven the efficacy of the rotational technical for I-gel™ insertion and reported a success rate of 97%. However, the rotation of i-gel™ in the oral cavity may be limited, and it may take some learning curve to get used to it. According to previous studies, head and neck rotation increases the cross-sectional area of the upper airway, which resulted in increasing patency of the upper airway. Therefore, the purpose of this study is to verify whether head and neck rotation increases the first attempt success rate of i-gel™.

Interventions

Insert I-gel™ according to the manufacturer's instruction. Take the sniffing position and gently move the i-gel™ along the hard palate to the soft palate and the posterior oropharynx.

PROCEDUREHean and Neck Rotation

After rotating the patient's head and neck to the left maximally, insert the i-gel™ from the right side of the tongue to the midline. When the tip reaches the soft palate and oropharynx positions, turn the head and neck back to the neutral position.

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ASA Physical Status Classification Grade 1-3 * Patients who can provide written consent to participate in clinical trials * Patients requiring the I-gel™ during surgery

Exclusion criteria

* Outpatient surgery * Patients who have the neurologic disease or cognitive impairment * Patients who take antipsychotic drugs * Body mass index \> 35 kg/m2 * Mouth opening \< 2.5 cm * Limited neck extension or cervical mobilization (Ex: Atlanto-axial subluxation, History of cervical spine surgery or head and neck surgery) * Those with a recent sore throat * Those with weak dentation * Patients at risk of aspiration (Ex: Pregnancy, Gastroesophageal reflux disease or hiatus hernia)

Design outcomes

Primary

MeasureTime frameDescription
First attempt success rateInduction of anesthesia during intraoperative periodAfter the first attempt on insertion of i-gel™ without withdrawal or redirection, the effectiveness of the airway is judged based on a square-wave capnograph and no audible leak with peak airway pressures ≥ 10 cmH2O during manual ventilation.

Secondary

MeasureTime frameDescription
Second attempt success rateInduction of anesthesia during intraoperative periodAfter the second attempt on insertion of i-gel™, the effectiveness of the airway is judged based on a square-wave capnograph and no audible leak with peak airway pressures ≥ 10 cmH2O during manual ventilation.
Time required for successful insertion; sInduction of anesthesia during intraoperative periodTime insertion of i-gel™ into the oral cavity until After the first attempt on insertion of i-gel™ without withdrawal or redirection, the effectiveness of the airway is judged based on a square-wave capnograph and no audible leak with peak airway pressures ≥ 10 cmH2O during manual ventilation.
Third attemptInduction of anesthesia during intraoperative periodIf the attempt of assigned method fails twice, then try third attempt.
Third attempt success rateInduction of anesthesia during intraoperative periodIf the attempt of assigned method fails, but the third attempt is successful with another method.
Manipulations required rateInduction of anesthesia during intraoperative periodAn assistant assists when all attempt fail.
Insertion time for successful insertion; sInduction of anesthesia during intraoperative periodTime from insertion of i-gel™ into the oral cavity until appropriate placement.
Blood staining after extubationInduction of anesthesia during intraoperative periodBlood stating to evaluate the postoperative complication and outcome in patients received each intubation method during surgery
Sore throat after extubationExtubation during intraoperative periodSore throat to evaluate the postoperative complication and outcome in patients received each intubation method during surgery
Hoarseness after extubationExtubation during intraoperative periodHoarseness to evaluate the postoperative complication and outcome in patients received each intubation method during surgery
Sore throat at 24 hours after surgery24 hours after surgery (up to 24hours)Sore throat to evaluate the postoperative complication and outcome in patients received each intubation method during surgery
Hoarseness at 24 hours after surgery24 hours after surgery (up to 24hours)Hoarseness to evaluate the postoperative complication and outcome in patients received each intubation method during surgery
Change to intubationInduction of anesthesia during intraoperative periodConversion rate from insertion of i-gel™ to tracheal intubation.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026